Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Criticare Systems and Fukuda Denshi have received approval from the Japanese Pharmaceutical and Medical Device Agency to sell and market CSI's gas technology in Japan.
Subscribe to our email newsletter
The Japan agency has granted Japanese good manufacturing practice (GMP) approval, enabling the sale of Criticare Systems’s (CSI) gas technology in the Japanese market. This represents an important milestone for both Criticare Systems and OEM partner Fukuda Denshi as it provides an exciting opportunity for continued growth of the gas monitoring business.